Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and PerspectivesFabiana Alves, Jorge Alvar, Monique Wasunna et al.|Clinical Microbiology Reviews|2018Cited by 218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in BangladeshRidwanur Rahman, Bhawna Sharma, Vishal Goyal et al.|PLoS neglected tropical diseases|2017Cited by 78
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Fabiana Alves, Vidya Nand Rabi Das et al.|PLoS neglected tropical diseases|2020Cited by 37
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, IndiaVishal Goyal, Jorge Alvar, Raman Mahajan et al.|PLoS neglected tropical diseases|2018Cited by 25
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, IndiaVishal Goyal, Jorge Alvar, Sakib Burza et al.|PLoS neglected tropical diseases|2019Cited by 15